An immunotherapy treatment based on administration of anti-cancer cell immunoglobulins showed efficacy following the expansion of a CD4 T cell subset characterized by expression of CD44, CXCR3, ICOS and the transcription factor T-bet [148,151,152]. The gene discussed is CD4; the disease is cancer.